Page last updated: 2024-09-03

tazobactam and Diabetes Mellitus

tazobactam has been researched along with Diabetes Mellitus in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huntington, JA; Long, J; Popejoy, MW	1
Chao, CM; Chiu, YH; Hou, CC; Lai, CC; Liu, WL	1
Chang, LK; Tsai, WC	1

Trials

1 trial(s) available for tazobactam and Diabetes Mellitus

Article	Year
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections	2017

Article

Year

Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.

BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1

Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections

2017

Other Studies

2 other study(ies) available for tazobactam and Diabetes Mellitus

Article	Year
Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient. Infection, 2011, Volume: 39, Issue:5 Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting	2011
Morganella morganii causing solitary liver abscess complicated by pyopericardium and left pleural effusion in a nondiabetic patient. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2002, Volume: 35, Issue:3 Topics: Diabetes Mellitus; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Leukocyte Count; Liver Abscess; Middle Aged; Morganella morganii; Penicillanic Acid; Pericardium; Piperacillin; Pleural Effusion; Radiography; Suppuration; Tazobactam	2002

Article

Year

Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.

Infection, 2011, Volume: 39, Issue:5

Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting

2011

Morganella morganii causing solitary liver abscess complicated by pyopericardium and left pleural effusion in a nondiabetic patient.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2002, Volume: 35, Issue:3

Topics: Diabetes Mellitus; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Leukocyte Count; Liver Abscess; Middle Aged; Morganella morganii; Penicillanic Acid; Pericardium; Piperacillin; Pleural Effusion; Radiography; Suppuration; Tazobactam

2002